Up to now, 13 out of the top 50 TCM producers have been listed publicly on Chinese domestic stock exchanges. There are 14 state-owned TCM companies, each achieving annual sales of US $24 million in 1996. A total of 14 Chinese finished TCM producers have passed the GMP certification conducted by the Australian and German pharmaceutical administrations.
The government encourages the establishment of large-scale TCM production enterprises by mergers and acquisitions. Five companies are expected to reach annual sales of RMB 2-3 billion (US $240-360 million) each by the year 2000. The government aims to form a TCM multinational company with sales of more than US $1 billion by the year 2010.
[Yuquan W. China Medipharm Insights. April 8, 1998.]
Article copyright American Botanical Council.
By Peter Landes